Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
CRISPR Therapeutics Announces the Appointment of Siva Sakhamuri, Ph.D., as Chief Technical Officer
GlobeNewswire, Inc.
ZUG, Switzerland and BOSTON, Nov. 02, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), today announced the appointment of Sivakesava (Siva) Sakhamuri, Ph.D., as Chief Technical Officer, effective immediately.
Nouscom Raises €120 Million ($135 Million) in Oversubscribed Series D Financing and will Present Long-Term Cancer Interception Clinical Data in Lynch Syndrome Carriers at ESMO
GlobeNewswire, Inc.
Oversubscribed €120 million Series D financing was led by M Ventures and Revelation Partners, with new investors Angelini Industries, the European Investment Bank and Neva SGR and participation from all existing investors.
ICPO ACADEMY FOR THERANOSTICS Launches Advanced Program in Radiomolecular Precision Oncology
GlobeNewswire, Inc.
Online curriculum expands with advanced clinical cases in prostate cancer and neuroendocrine tumors including multidisciplinary tumor board illustrations Wiesbaden, November 2, 2026 – Radiomolecular Precision Oncology, also known as Theranostics,...
Oculis Appoints Experienced Life Sciences Leader Björn Tackenberg, M.D., Ph.D., as Chief Scientific Officer to Advance Neurology Innovation
GlobeNewswire, Inc.
Björn Tackenberg, M.D. Ph.D. FEAN FAAN, Professor of Neurology, will lead Oculis’ global integrated scientific strategy supporting the advancement of Privosegtor and its expansion into new therapeutic applications Aaron Tansy, M.D., appointed as...
Ondine Completes £10M Financing to Advance US Regulatory Pathway and International Commercialisation of Steriwave
EIN Presswire
VANCOUVER, CANADA, November 2, 2026 /EINPresswire.com/ -- Ondine Biomedical Completes £10M Financing to Advance US Regulatory Pathway and International Commercialisation of Steriwave its Nasal Photodisinfection Technology to Reduce Infections in...
SGI Hosts Zurich Executive Event on the Human Premium in the Age of AI
EIN Presswire
Invitation-only evening on October 22nd 2026 brings Swiss technology and business leaders together to discuss leadership, judgement and workforce strategy ZURICH, SWITZERLAND, October 15, 2026 /EINPresswire.com/ -- Source Group International...
Revolution Medicines’ RASONQUE(™) (daraxonrasib) Receives Positive CHMP Opinion Recommending Marketing Authorization in European Union for Metastatic Pancreatic Cancer
GlobeNewswire, Inc.
Recommendation based on results from Phase 3 RASolute 302 trial, which demonstrated a 60% reduction in risk of death compared with chemotherapy in the overall study population with statistically significant and clinically meaningful improvements...
EXIT-CVD research consortium launches clinical studies to transform cardiovascular care across Europe
GlobeNewswire, Inc.
October 15, 2026 Five-year research project unites 42 public and private partners across 17 countries to conduct 22 clinical studies involving 14,000+ patients; first patients will be enrolled this month Project aims to help cardiac patients avoid...
Belite Bio Announces Multi-Market Submission of Marketing Authorization Applications Via the Access Consortium Pathway for Tinlarebant for the Treatment of Stargardt Disease Type 1
GlobeNewswire, Inc.
If approved, tinlarebant would be the first-ever approved treatment for Stargardt Disease Type 1 in Singapore, United Kingdom, and Switzerland Access pathway submission combined with accepted new drug applications in the U.S. (Prescription Drug...
Korean Scalp Care Brand HISTEMO Brings Its Professional Program to the US
EIN Presswire
Yewon HISTEMO offers US salons and scalp specialists a Korean scalp care program built on growth factors, peptides, products and training.
Nxera Pharma Enters into Exclusive License, Supply and Commercialization Agreement with Synmosa for QUVIVIQ® (daridorexant) Across Eight Asia-Pacific Markets
GlobeNewswire, Inc.
Synmosa to lead regulatory approvals, market access, distribution and sales in Singapore, Thailand, Indonesia, Malaysia, the Philippines, Vietnam, Australia and New Zealand.
HUTCHMED Announces Regulatory Filings Accepted for Review for ORPATHYS® plus TAGRISSO® in MET-Driven EGFR-Mutated Lung Cancer in Europe and Japan
GlobeNewswire, Inc.
— Follows US FDA new drug application submission in September 2026, marking important global regulatory progress — — Filings supported by positive SAFFRON global Phase III data demonstrating statistically significant and clinically meaningful PFS...
Bavarian Nordic Awarded Multi-Year Vaccine Contract by UK Government
GlobeNewswire, Inc.
COPENHAGEN, Denmark, November 2, 2026 – Bavarian Nordic A/S (OMX: BAVA) today announced that it has been awarded a new multi-year contract by the UK Government through the UK Health Security Agency (UKHSA) for the supply of MVA-BN®, a...
64K Cellssense Combines Swiss Expertise and Delivery Science for Longevity
EIN Presswire
Exclusive MPNutria® technology and collaboration with Clinique Eden Suisse inform sustained research and innovation for healthy aging GENEVA, GENEVA, SWITZERLAND, October 12, 2026 /EINPresswire.com/ -- 64K Cellssense, a Swiss-rooted longevity...
AELO Swiss Academy Highlights Integrated ATPL Program for Aspiring Airline Pilots
GlobeNewswire, Inc.
GORDOLA, SWITZERLAND, Oct. 13, 2026 (GLOBE NEWSWIRE) -- GORDOLA, SWITZERLAND - October 13, 2026 - AELO Swiss Academy has detailed the structure and outcomes of its flagship pilot training pathway, the Integrated ATPL Program, a comprehensive...
China’s Permanent Representative to the United Nations Office at Geneva and Other International Organizations in Switzerland Ambassador Jia Guide Meets with H.E. Ms. Zanariah Zainal Abidin, Permanent Representative of Malaysia
Ministry of Foreign Affairs of the People's Republic of China
On October 8, 2026, Ambassador Jia Guide, Permanent Representative of China to the United Nations Office at Geneva and other International Organizations in Switzerland, met with H.E. Ms. Zanariah Zainal Abidin, Permanent Representative of...
Acoramidis Associated with Significantly Improved Clinical Outcomes Versus Tafamidis in ATTR-CM in an Independent, Real-World Study of U.S. Electronic Health Records
GlobeNewswire, Inc.
- In an independent, propensity score-matched analysis of 2,684 individuals living with ATTR-CM from Epic COSMOS, the largest U.S. electronic health record database, acoramidis was associated with a statistically significant 18% lower risk of a...
Aprocitentan efficacy data reinforce endothelin pathway blockade as a distinct therapeutic approach across the cardiometabolic disease spectrum including obesity
GlobeNewswire, Inc.
Two oral presentations at AHA Hypertension 2026 demonstrate the pronounced efficacy of aprocitentan in two groups of patients with notoriously difficult to control hypertension from the PRECISION study: patients with obesity and patients across...
Nouscom Strengthens Leadership and Operational Capabilities, Appointing Loredana Siani, Ph.D., as Chief Technology Officer
GlobeNewswire, Inc.
Nouscom Strengthens Leadership and Operational Capabilities, Appointing Loredana Siani, Ph.D., as Chief Technology Officer Promotion follows recent €120 million Series D financing as Nouscom advances NOUS-209 into registration-enabling trial in...
Newron Provides Update on FDA Clinical Hold and Phase 3 ENIGMA-TRS Development Program
GlobeNewswire, Inc.
Management call today at 3.30 pm CEST Newron received the anticipated FDA written communication on clinical hold at U.S. study centers and is reviewing feedback and preparing its response ENIGMA-TRS 1 enrollment expected to be completed by...
Sign up for:
Switzerland Health Monitor
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.